Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Paralysis

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Paralysis in 1 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Paralysis: A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asmundsson, G1
Caringi, D1
Mokler, DJ1
Kobayashi, T1
Ishide, T1
Ally, A1

Other Studies

1 other study available for 8-hydroxy-2-(di-n-propylamino)tetralin and Paralysis

ArticleYear
Extracellular serotonin changes in VLM during muscle contraction: effects of 5-HT1A-receptor activation.
    The American journal of physiology, 1997, Volume: 273, Issue:6

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Blood Pressure; Electric Stimulation; Heart Rate; K

1997